Vaughan David Investments LLC IL Has $73.44 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Vaughan David Investments LLC IL cut its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 139,492 shares of the healthcare conglomerate’s stock after selling 1,624 shares during the period. UnitedHealth Group comprises about 2.0% of Vaughan David Investments LLC IL’s holdings, making the stock its 2nd biggest position. Vaughan David Investments LLC IL’s holdings in UnitedHealth Group were worth $73,438,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently modified their holdings of UNH. Robbins Farley purchased a new position in UnitedHealth Group in the third quarter valued at approximately $25,000. Richelieu Gestion SA purchased a new position in UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC lifted its stake in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the last quarter. NewSquare Capital LLC lifted its stake in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA lifted its position in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UNH traded down $2.81 during trading on Friday, reaching $438.91. The stock had a trading volume of 6,042,964 shares, compared to its average volume of 4,289,546. The business has a 50-day moving average of $493.72 and a 200-day moving average of $516.67. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The stock has a market cap of $404.64 billion, a PE ratio of 18.37, a PEG ratio of 1.23 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. During the same period last year, the firm earned $5.34 earnings per share. The company’s revenue for the quarter was up 14.1% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.75 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.71%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.54%.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on UNH shares. Wells Fargo & Company dropped their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Wednesday. Barclays started coverage on UnitedHealth Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 target price on the stock. Royal Bank of Canada restated an “outperform” rating and set a $596.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 29th. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Three research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $576.48.

Get Our Latest Stock Report on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.